utd_medknow
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :994
Small font sizeDefault font sizeIncrease font size
Resource Links
     Search Pubmed for
 
    -  Mahajan NS
    -  Pillai R
    -  Chopra H
    -  Grover A
    -  Kohli A
 

 Article Access Statistics
    Viewed111    
    PDF Downloaded8    

Recommend this journal

 

 ORIGINAL ARTICLE

An economic model to assess the value of triclosan-coated sutures in reducing the risk of surgical site infection in a mastectomy in India


1 Medical Affairs, Clinical Operations and Device Safety, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India
2 Ethicon Sales and Marketing Team, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India

Correspondence Address:
Nilesh S Mahajan,
Medical Affairs, Clinical Operations and Device Safety, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijc.IJC_1000_19

Background: The comparison of triclosan-coated sutures (TCS) was made with conventional nonantimicrobial-coated sutures (NCS) to reduce surgical site infection (SSI). This study demonstrates the efficacy and economic outcome of TCS versus NCS for SSIs in mastectomy in India. Methods: In this retrospective analysis, 100 patients were included for both conditions—TCS and NCS—from a private and public hospital in India. A systematic literature search of available evidence for both SSI incidences and TCS efficacy data in India were gathered. We collected cost data from a private and public hospital, respectively, for mastectomy in India. The cost-effectiveness of TCS in comparison with the conventional NCS was calculated using a decision-tree deterministic model. We performed a one-way sensitivity analysis to compare TCS with NCS. Results: Cost savings with the use of TCS increased with an increase in SSI incidence and an increase in efficacy for mastectomies in both public and private hospitals. We found a base cost saving of Indian rupees (INR) 27,299 at a private hospital and INR 2,958 at a public hospital for mastectomies. The incremental cost of TCS suture was 0.01% in a private hospital whereas 0.17% in a public hospital. Conclusion: The use of TCS resulted in reduced SSI incidence and cost savings for mastectomy in India.




  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow